Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,719 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study.
Kim YH, Park DW, Ahn JM, Yun SC, Song HG, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Jang Y, Jeong MH, Kim HS, Hur SH, Rha SW, Lim DS, Her SH, Seung KB, Seong IW, Park SJ; PRECOMBAT-2 Investigators. Kim YH, et al. Among authors: kim wj, kim hs. JACC Cardiovasc Interv. 2012 Jul;5(7):708-17. doi: 10.1016/j.jcin.2012.05.002. JACC Cardiovasc Interv. 2012. PMID: 22814775 Free article. Clinical Trial.
Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans.
Suh JW, Park JS, Cho HJ, Kim MS, Kang HJ, Cho YS, Koo BK, Chung WY, Youn TJ, Chae IH, Choi DJ, Kim HS, Sohn DW, Oh BH, Park YB. Suh JW, et al. Among authors: kim ms, kim hs. Int J Cardiol. 2007 Apr 12;117(1):31-6. doi: 10.1016/j.ijcard.2006.03.009. Epub 2007 Feb 8. Int J Cardiol. 2007. PMID: 17292498 Clinical Trial.
Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study.
Koo BK, Kim YS, Park KW, Yang HM, Kwon DA, Chung JW, Hahn JY, Lee HY, Park JS, Kang HJ, Cho YS, Youn TJ, Chung WY, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS. Koo BK, et al. Among authors: kim ys, kim hs. Lancet. 2007 Aug 18;370(9587):567-74. doi: 10.1016/S0140-6736(07)61295-1. Lancet. 2007. PMID: 17707751 Clinical Trial.
Stents versus coronary-artery bypass grafting for left main coronary artery disease.
Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. Seung KB, et al. Among authors: kim yh, kim pj, kim hs. N Engl J Med. 2008 Apr 24;358(17):1781-92. doi: 10.1056/NEJMoa0801441. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378517 Free article.
Efficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: study design and rationale of a Korean multicenter prospective randomized trial.
Park KW, Yoon JH, Kim JS, Hahn JY, Cho YS, Chae IH, Gwon HC, Ahn T, Oh BH, Park JE, Shim WH, Shin EK, Jang YS, Kim HS. Park KW, et al. Among authors: kim js, kim hs. Am Heart J. 2009 May;157(5):811-817.e1. doi: 10.1016/j.ahj.2009.02.008. Am Heart J. 2009. PMID: 19376305 Clinical Trial.
15,719 results
You have reached the last available page of results. Please see the User Guide for more information.